Navigation Links
Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates
Date:4/29/2008

of 10-year senior notes. Medco used the net proceeds from the sale of these senior notes to repay borrowings under its revolving credit facility used to fund the PolyMedica acquisition.

Share Repurchase Program

In conjunction with its $5.5 billion share repurchase program, Medco repurchased 21 million shares at a cost of $1 billion during the first quarter, representing an average per-share cost of $47.55. From the inception of the share repurchase program in 2005 through the end of the first quarter of 2008, Medco has repurchased 132.4 million shares at a total cost of $4.5 billion, with an average per-share cost of $34.10.

Specialty Pharmacy Segment

Revenues for Medco's specialty pharmacy segment, Accredo Health Group, achieved a new record and grew 30.3 percent to nearly $1.9 billion, compared to $1.4 billion in the first quarter of 2007, primarily the result of the contribution from significant new clients commencing in January 2008, and the addition of Critical Care Systems in fourth-quarter 2007.

Gross margin in first-quarter 2008 of 7.7 percent declined from 8.0 percent in first-quarter 2007, reflecting new client mix and start-up costs from new client installations. Operating income rose 19.1 percent, to $63.7 million from $53.5 million in the first quarter of 2007, driven by increased mail-order volume from the new business.

Reaffirming 2008 Guidance

For full-year 2008, Medco continues to expect GAAP diluted earnings per share in the range of $2.07-$2.11, representing growth of 27-29 percent over 2007. Diluted earnings per share in 2008, excluding the effect of amortization of intangibles that existed when Medco became a public company, continue to be projected in the range of $2.27-$2.31, a growth rate of 25-27 percent over 2007. (Please see Table 9 for a reconciliation of earnings per share guidance).

Use of Non-GAAP Measures

Medco calculates and uses EBITDA and EBITDA per adjusted prescriptio
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Medco CEO to Present at the Morgan Stanley Global Healthcare Unplugged Conference
2. Medco, UnitedHealth Group Announce Pharmacy Services Agreement
3. PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
4. Medco Acquires Majority Interest in Europa Apotheek; Delivering Innovation, Clinical Quality and Lower-Cost Solutions to Fast-Growing German Health Care Market
5. Medco Partners to Develop Patient-Safety System for Prescription Drugs in Sweden
6. MedCom Announces Card Activation Wins Significant Court Ruling
7. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
8. Medco Breaks Ground For Worlds Largest Automated Pharmacy
9. Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences
10. Medco Tops Fortunes List of Americas Most Admired Companies in its Industry
11. MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2014)... RECIST Working Group published in the European Journal of ... categorization of tumor response or various aspects of progression could ... They found that modeling target lesion tumor growth did not ... of the other components of progression. The RECIST Working Group ...
(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
(Date:4/14/2014)... Henry Ford Hospital reached a medical milestone April 3, ... novel way to access the heart. , Henry Ford ... the unique procedure called transcaval valve replacement, which accesses ... Northern Michigan resident Viola Waller, 80, underwent Henry Ford,s ...
(Date:4/14/2014)... , , Penicillin, one of the scientific marvels of the ... it once won against bacterial infections. But scientists at ... new approach to restoring its combat effectiveness, even against ... the power of the penicillin family of drugs since ...
(Date:4/14/2014)... an active role in their radiation treatment decisions leaves ... may even relieve psychological distress around the experience, researchers ... University of Pennsylvania report in the journal ... undergoing radiation treatment, Neha Vapiwala, MD , an ...
Breaking Medicine News(10 mins):Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Nano shake-up 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3
... Each year the American Institute of Biological Sciences ... contributions to the biological sciences. The AIBS ... to announce the following award winners for 2009: ... PhD, University of Washington, Outstanding Service Award: Robert ...
... Calif., May 15 Cord Blood America, Inc. (OTC ... preservation company ( http://www.cordblood-america.com ) ... cells to families nationwide and internationally, said today that ... In audio interview with analyst Francis Gaskins, explains the ...
... 15 The YWCA USA presented its prestigious 2009 ... Justice and YWCA Niagara for Women,s Economic Advancement at ... Washington, D.C. They were selected among six exemplary initiatives ... , , YWCA Central Massachusetts was honored ...
... Cigna Medical Group has announced the opening of its ... the total number of CareToday clinics to six.CareToday Anthem ... Daisy Mountain Drive and Gavilan Peak Parkway, 39510 North ... practitioners and physician assistants, the clinics offer after hours ...
... to be the fourth fatality in the U.S. , , FRIDAY, ... the swine flu outbreak has yet to run its current ... schools were closed Thursday after dozens of flu-like infections surfaced ... ventilator, according to published reports. , Meanwhile, a woman in ...
... with trastuzumab (Herceptin) to treat women who have metastatic ... their treatment options. , At the 45th Annual Meeting ... (ASCO), researchers from the Mayo Clinic campus ... vinorelbine, and trastuzumab offers a treatment option that is ...
Cached Medicine News:Health News:AIBS honors outstanding contributions to biology 2Health News:AIBS honors outstanding contributions to biology 3Health News:AIBS honors outstanding contributions to biology 4Health News:AIBS honors outstanding contributions to biology 5Health News:Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory 2Health News:Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory 3Health News:YWCA USA 2009 Hallmark Initiative Awards Presented to YWCA Central Massachusetts and YWCA Niagara 2Health News:Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz. 2Health News:Swine Flu Closes Three Schools in NYC 2Health News:Swine Flu Closes Three Schools in NYC 3Health News:Swine Flu Closes Three Schools in NYC 4Health News:Swine Flu Closes Three Schools in NYC 5Health News:Swine Flu Closes Three Schools in NYC 6Health News:Swine Flu Closes Three Schools in NYC 7Health News:Swine Flu Closes Three Schools in NYC 8Health News:Swine Flu Closes Three Schools in NYC 9Health News:Triple drug combination is promising option to treat metastatic HER2+ breast cancer 2Health News:Triple drug combination is promising option to treat metastatic HER2+ breast cancer 3
(Date:1/15/2014)... 15, 2014 BreedIT Corp (OTC: BRDT), ... distributor of highly sophisticated agro-breeding solutions for plant breeders ... the Company,s board of directors appointed chemistry and pharmaceutical ... new member of the board. From 1975 ...
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary ... common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... , May 25 A record 235 new ... being developed by America,s pharmaceutical research and biotechnology companies, according to a ... , , ... adult population suffers from diabetes—a rate that has more than doubled since ...
... HELMOND, The Netherlands , May 25, 2010 Blue Medical ... life of,patients with cardiovascular disease, with the start of the PIONEER trial, in,which ... , , ... clinical program, is the trial that,enables for the first time the delivery of ...
Cached Medicine Technology:New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes 2New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes 3New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes 4First Coronary Stent on Drug Eluting Balloon Implanted 2
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Serrated tips, straight platforms....
Curved shafts with fine pointed tips. Smooth handle with dull finish....
Medicine Products: